1st Circ. Considers Rejecting $24M Zoladex Deal

Law360, New York (October 9, 2009, 2:34 PM EDT) -- In a dispute over whether the agreement was unfair, a federal appeals court is considering whether to reject a $24 million settlement in a suit brought by consumers against AstraZeneca Pharmaceuticals LP over alleged gross inflating of prices for prostate cancer drug Zoladex.

The U.S. Court of Appeals for the First Circuit heard arguments Thursday over plaintiff M. Joyce Howe's challenge to the settlement, in which she and her attorney Donald E. Haviland argued that the settlement was improperly negotiated, includes too many purported class members,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.